StockData

Intercure Ltd. (INCR) stock

INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 3/30
$3.61−0.02 (-0.55%)

Close on Nov 17, 2026Market cap $197.40MP/E –Yield –

Intercure revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was 270.20M ILS, up 13.1% from the year before. The highest annual figure on record is 388.68M ILS in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025270.20M ILS+13.1%
FY2024Dec 31, 2024238.85M ILS-32.8%
FY2023Dec 31, 2023355.55M ILS-8.5%
FY2022Dec 31, 2022388.68M ILS+76.9%
FY2021Dec 31, 2021219.68M ILS+237.8%
FY2020Dec 31, 202065.04M ILS+628.6%
FY2019Dec 31, 20198.93M ILS–

More Intercure figures

See a number that looks wrong?